Fanfei Kong

miR-424(322) reverses chemoresistance via T-cell immune response activation by blocking the PD-L1 immune checkpoint

Shaohua Xu, Zhen Tao, Bo Hai et al. · Nature Communications · 2016 · 290 citations · Full text

Medicine, Immunology, Oncology +17

MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1

Shaohua Xu, Guangbo Fu, Zhen Tao et al. · Oncotarget · 2015 · 103 citations · Full text

Medicine, Oncology, Radiation Oncology +17

LINC01016 promotes the malignant phenotype of endometrial cancer cells by regulating the miR-302a-3p/miR-3130-3p/NFYA/SATB1 axis

Xin Pan, Da Li, Jianing Huo et al. · Cell Death and Disease · 2018 · 94 citations · Full text

Medicine, Cancer Biology, Oncology +17

miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1

Fanfei Kong, Chaoyang Sun, Zhongxian Wang et al. · Journal of Huazhong University of Science and Technology [Medical Sciences] · 2011 · 86 citations

Medicine, Cancer Biology, Oncology +16

Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer

Rong Cong, Fanfei Kong, Jian Ma et al. · BMC Cancer · 2020 · 75 citations · Full text

Medicine, Gynecology, Oncology +14